Dr Fassil Brian Mesfin, MD, PHD | |
1100 Virginia Ave, Columbia, MO 65212-0001 | |
(573) 882-2663 | |
(573) 882-5847 |
Full Name | Dr Fassil Brian Mesfin |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 19 Years |
Location | 1100 Virginia Ave, Columbia, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992968218 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
University Health System | San antonio, TX | Hospital |
Baptist Medical Center | San antonio, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Texas Health Science Center At San Antonio | 0042128548 | 1057 |
News Archive
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
For the first time in history, the complications of preterm birth outrank all other causes as the world's number one killer of young children.
A Norwegian study shows that impairment in mitochondria may actually protect the brain in Parkinson's disease.
A shorter duration of untreated psychosis is associated with improved long-term outcomes in patients with schizophrenia, researchers report.
› Verified 2 days ago
Entity Name | University Of Texas Health Science Center At San Antonio |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720051717 PECOS PAC ID: 0042128548 Enrollment ID: O20040607000664 |
News Archive
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
For the first time in history, the complications of preterm birth outrank all other causes as the world's number one killer of young children.
A Norwegian study shows that impairment in mitochondria may actually protect the brain in Parkinson's disease.
A shorter duration of untreated psychosis is associated with improved long-term outcomes in patients with schizophrenia, researchers report.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Fassil Brian Mesfin, MD, PHD Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Dr Fassil Brian Mesfin, MD, PHD 1100 Virginia Ave, Columbia, MO 65212-0001 Ph: (573) 882-2663 |
News Archive
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
For the first time in history, the complications of preterm birth outrank all other causes as the world's number one killer of young children.
A Norwegian study shows that impairment in mitochondria may actually protect the brain in Parkinson's disease.
A shorter duration of untreated psychosis is associated with improved long-term outcomes in patients with schizophrenia, researchers report.
› Verified 2 days ago
Dr. O. Gerald Orth, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2404 Beachview Dr, Columbia, MO 65203 Phone: 573-445-6174 | |
Dr. Charles P. Bondurant, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1605 E Broadway, Suite 100, Columbia, MO 65201 Phone: 573-815-4242 Fax: 573-815-4245 | |
Dr. Fareed R Jumah, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-3957 | |
Carolyn Sue Quinsey, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-4908 Fax: 573-884-5184 | |
Lori R Darr, APRN Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: One Hospital Drive, Columbia, MO 65212 Phone: 573-884-8646 Fax: 573-884-5184 | |
Dr. Bornali Kundu, M.D., PH.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-4908 Fax: 573-884-5184 | |
Tomoko Tanaka, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65201 Phone: 573-882-4908 Fax: 573-884-5184 |